Deep Rectus Sheath Block for Laparoscopic Cholecystectomy

Condition(s) studied

Investigational drug(s) / intervention(s)

Intravenous morphine patient control analgesia: 24-hour morphine consumption will be recorded

Intravenous patient control analgesia: 24-hour morphine consumption will be recorded

Deep rectus sheath block: Deep rectus sheath block will be administered at the end of the surgery.

Study summary

Postoperative pain after laparoscopic cholecystectomy can be considerable. Regional techniques such as erector spinae plane (ESP) block or transversus abdominis plane (TAP) block may be suitable for patients at increased risk of postoperative pain. The deep rectus sheath block is a novel block which is a modified version of the conventional rectus sheath block. It was reported in a few case reports that, it may be used for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. The aim of this study is to investigate the postoperative analgesic efficacy of deep rectus sheath block in patients undergoing laparoscopic cholecystectomy.

Eligibility

Primary outcome measure(s)

• Morphine consumption — Postoperative 24 hours
  The amount of morphine required by the patient and given by the device will be recorded for the first 24 hours.

Trial sites (1)

More Istinye University trials in Turkey

Other trials for the same condition